Molecular Characterization of the Resistance of Mycobacterium tuberculosis to Second Line Drugs in Côte d’Ivoire

Purpose: To characterize the resistance of Mycobacterium tuberculosis to second line drugs using a line probe assay.Methods: Multi-drug resistant strains of Mycobacterium tuberculosis isolated between December 2008 and December 2009 were tested for resistance to fluoroquinolones and second-line injectable drugs using GenoType® MTBDRsl.Results: Thirty eight strains gave interpretable results. None of them had a mutation in the gyrA gene. Regarding second-line injectable drugs, 4 strains (11 %) were resistant to aminoglycosides/ capreomycin and all of them harbored A1401G mutation.Conclusion: No extensive drug resistant strains were observed. A relatively high proportion of strains were resistant to at least one second-line injectable drug. Resistance mechanism seemed similar for all of them.Keywords: Mycobacterium tuberculosis, Line probe assay, GenoType® MTBDRsl, Aminoglycosides Capreomycin, Mutatio

Recombinant Poliovirus circulation among healthy children immunized with oral polio vaccine in Abidjan

In order to assess the level of polio virus with natural recombinant genome and wild polio virus circulating in the environment of healthy children aged 0 to 5 years in Abidjan, 130 polio viruses made up of 26 polio type 1, 55 type 2 and 49 type 3 were identified by neutralisation test with monoclonal antibodies and restriction fragment length polymorphism (RFLP) targeting the VP1 and 3D1 gene. Four wild non Sabin-like (NSL) strains (3.1%): one type 2 and three type 3 were identified in non vaccinated children. One hundred and six (81.5%) isolates were Sabin-like, 20 (15.4%) were recombinant with the following polio virus profiles: 2 Sabin-like type 1/type 2, 3 Sabin-like type 3/type 1, 11 Sabin-like type 3/type 2 and one polio virus type 3 NSL/Sabin-like type 3. Intertypic vaccine/vaccine or vaccine/wild strain recombinant polio virus circulating among healthy children rate was high and suggested the need for a molecular surveillance of vaccine strains. Oral Polio Vaccine (OPV) strains are well-known to revert to pathogenicity in vaccines. Therefore, the long term excretion of pathogenic OPV derived strains by some vaccinees needs to be considered quite seriously. It therefore suggested that all polio virus isolated from acute flaccid paralysis (AFP) be analyzed by restriction fragment length polymorphism and sequencing of the viral genome. Key words: polio virus, recombinant virus, healthy children, Cote d'Ivoire. African Journal of Biotechnology Vol.3(5) 2004: 289-29

Essai préliminaire de mise en oeuvre de culture de cyanobactérie en Côte d’Ivoire

Les cyanobactéries sont des bactéries photosynthétiques capable produire des métabolites secondaires dont les cyanotoxines. Les blooms à  cyanobactérie toxiques représentent des menaces aussi bien pour l’environnement que l’homme et les animaux. L’étude des toxines et autres métabolites nécessitent des cultures viables de cyanobactérie. Cependant, la culture in vitro de cyanobactérie en Côte d’Ivoire est peu développée. Cette étude s’est donnée pour objectif d’expérimenter la culture in vitro de cyanobactérie à partir d’échantillon de phytoplankton récolté dans la nature. Une revue de la littérature a servi de base à cette étude. Elle a permis d'identifier un site de prélèvement, des techniques et des clés d'identification des cyanobactéries. Elle a également permis la sélection de milieux de culture à utiliser. Un « incubateur artisanal » a été développé pour la culture de cyanobactéries. Le milieu Bold modifié (M1) était statistiquement le plus adapté à la culture des cyanobactéries en général. La composition de ce milieu pourrait avoir favorisé le  développement de certains genres aux détriments d’autres. La culture de cyanobactéries a été mise en oeuvre. Il reste cependant à améliorer la technique à poursuivre vers la purification des cultures et l’étude des  métabolites secondaires. Keywords : Cyanobacterie, Culture, Environnement, Identification, Côte d’Ivoire

First molecular investigation of capsular serotyping and hypervirulent (hvlp) of K. Pneumoniae in university hospital center of yopougon cote d'ivoire

Klebsiella pneumoniae is a well known human pathogen. Although infectious in most nosocomial infections with a high level of resistance, capsular types and circulating hypervirulent strains in our context are not documented. The aims of this study are to identify capsular serotypes and hypervirulent strains circulating at the Yopougon University Hospital in Abidjan. 51 strains of Klebsiella were collected at Chu de Yopougon. The capsular serotypes were determined using PCR and the serotypes K1, K2 and K5 were searched. The hypervirulent strains were also investigated by PCR and by string test. The predominant serotypes were non-K1 / K2 (46/51, 90%). The serotypes found K5 and K2 in (4/51, 7.8%) and (1/51; 1.9%) respectively. The rmpA gene linked to hyperviscosity or hyperviscosity was not found although 25.5% (12/51) were positive for the stretch test. The capsular distribution of strains of Klebsiella pneumoniae seems different from Asian authors. The determination of non-K1non types K2 remains to be elucidated.Keyvords: Klebsiella pneumoniae, capsular serotype - hypervirulencePremiere etude d’investigation moleculaire de serotypage capsulaire et de gene d’hypervirence de klebsiella pneumniae au laboratoire du chu de yopougon en cote d’ivoireKlebsiella pneumoniae est un pathogène nosocomial humain bien connu. Bien qu’incriminé dans la plus part des infections nosocomiales avec un niveau élevé de résistance, les types capsulaires et les souches hypervirulentes circulantes dans notre contexte ne sont pas documentés. L’objectif de cette étude est d'identifier les sérotypes capsulaires et les souches hypervirulentes circulant au CHU de Yopougon Abidjan., 51 souches de Klebsiella ont été collectés au Chu de Yopougon. Les sérotypes capsulaires ont été déterminée à l’aide de la PCR et les sérotypes K1, K2 et K5 ont été recherchés. Les souches hypervirulentes ont été recherchées également par PCR et par le test d’étirement ou string test. Les sérotypes prédominants étaient les non K1/K2 (46/51; 90%). Les sérotypes retrouvés K5 et K2 dans respectivement (4/51; 7,8%) et (1/51 ; 1,9%). Le gène rmpA lié à l’hyperviscosité n’a pas été retrouvé bien que 25,5% (12/51) étaient positives au test d’étirement. La distribution capsulaire des souches de Klebsiella pneumoniae semble différente des auteurs asiatiques. D’ou l’intérêt de travaux plus approfondies afin de déterminer les types capsulaire des souches non K1 non K2.Mots clefs : Klebsiella pneumoniae – serotype capsulaire – Hypervirulenc

Estimating the burden of rubella virus infection and congenital rubella syndrome through a rubella immunity assessment among pregnant women in the Democratic Republic of the Congo: Potential impact on vaccination policy.

BACKGROUND: Rubella-containing vaccines (RCV) are not yet part of the Democratic Republic of the Congo's (DRC) vaccination program; however RCV introduction is planned before 2020. Because documentation of DRC's historical burden of rubella virus infection and congenital rubella syndrome (CRS) has been minimal, estimates of the burden of rubella virus infection and of CRS would help inform the country's strategy for RCV introduction. METHODS: A rubella antibody seroprevalence assessment was conducted using serum collected during 2008-2009 from 1605 pregnant women aged 15-46years attending 7 antenatal care sites in 3 of DRC's provinces. Estimates of age- and site-specific rubella antibody seroprevalence, population, and fertility rates were used in catalytic models to estimate the incidence of CRS per 100,000 live births and the number of CRS cases born in 2013 in DRC. RESULTS: Overall 84% (95% CI 82, 86) of the women tested were estimated to be rubella antibody seropositive. The association between age and estimated antibody seroprevalence, adjusting for study site, was not significant (p=0.10). Differences in overall estimated seroprevalence by study site were observed indicating variation by geographical area (p⩽0.03 for all). Estimated seroprevalence was similar for women declaring residence in urban (84%) versus rural (83%) settings (p=0.67). In 2013 for DRC nationally, the estimated incidence of CRS was 69/100,000 live births (95% CI 0, 186), corresponding to 2886 infants (95% CI 342, 6395) born with CRS. CONCLUSIONS: In the 3 provinces, rubella virus transmission is endemic, and most viral exposure and seroconversion occurs before age 15years. However, approximately 10-20% of the women were susceptible to rubella virus infection and thus at risk for having an infant with CRS. This analysis can guide plans for introduction of RCV in DRC. Per World Health Organization recommendations, introduction of RCV should be accompanied by a campaign targeting all children 9months to 14years of age as well as vaccination of women of child bearing age through routine services

Full Length Research Paper - Recombinant Poliovirus circulation among healthy children immunized with oral polio vaccine in Abidjan

In order to assess the level of polio virus with natural recombinant genome and wild polio virus circulating in the environment of healthy children aged 0 to 5 years in Abidjan, 130 polio viruses made up of 26 polio type 1, 55 type 2 and 49 type 3 were identified by neutralisation test with monoclonal antibodies and restriction fragment length polymorphism (RFLP) targeting the VP1 and 3D1 gene. Four wild non Sabin-like (NSL) strains (3.1%): one type 2 and three type 3 were identified in non vaccinated children. One hundred and six (81.5%) isolates were Sabin-like, 20 (15.4%) were recombinant with the following polio virus profiles: 2 Sabin-like type 1/type 2, 3 Sabin-like type 3/type 1, 11 Sabin-like type 3/type 2 and one polio virus type 3 NSL/Sabin-like type 3. Intertypic vaccine/vaccine or vaccine/wild strain recombinant polio virus circulating among healthy children rate was high and suggested the need for a molecular surveillance of vaccine strains. Oral Polio Vaccine (OPV) strains are well-known to revert to pathogenicity in vaccines. Therefore, the long term excretion of pathogenic OPV derived strains by some vaccinees needs to be considered quite seriously. It therefore suggested that all polio virus isolated from acute flaccid paralysis (AFP) be analyzed by restriction fragment length polymorphism and sequencing of the viral genome

Faecal Short-chain Fatty Acid and Early Introduction of Foods in the First 200 Days of Infant’s Life in the District of Abidjan (Ivory Coast)

Dosage of short chain fatty acids (SCFAs) according to food diet showed that the content of acetate was high in newborn feaces. Infants receiving food supplements have a complex and diverse gut microbiota. Moreover, the results show that infants from poor districts have an abundant concentration of SCFAs in their faeces compared to those living in places with a relatively high standard of living. Among infants receiving milk, the highest proportion of SCFA is acetate in breastfed infants (BF) at a rate of 15.025 ± 2.23 μmol/g, followed by propionate in infants receiving mixed feeding (BF+FF), at a rate of 13.58 ± 1.03 μmol/g and butyrate in infants taking mixed feeding at a rate of 0.32 ± 0.72 μmol/g. However, among infants starting early diet diversification, acetate is higher in infants receiving milk formula and diet diversification (FF+FD) with a concentration of 25.4 ± 0 μmol/g, followed by propionate (2.36 ± 0 μmol/g) in infants receiving mixed feeding (BF+FF) and butyrate in those fed with (BF+FD). Partial breastfeeding is associated with a higher proportion of acetate, butyrate and propionate. The study of the correlation between the different SCFAs produced and the ASV (Variants of Microbial Amplicon Sequences) of the intestinal community of the child, shows that acetate is positively correlated with Bifidobacterium and negatively with Streptococcus and Escherichia-Shigella. Propionate is positively correlated with Bifido bacterium and negatively with Escherichia-Shigella. Similarly, butyrate is positively correlated with Bifidobacterium and negatively with Escherichia-Shigella

Spoligotypes identified by a SIT number in the SITVIT database.

1<p>SIT: Shared International Type.</p>2<p>The black and white boxes indicate the presence and absence, respectively, of the specific spacer at positions 1–43 in the DR locus.</p>3<p>Clade designations according to SpolDB4 database.</p